Thursday, January 26, 2012

GERON the future in bio-tech: Geron up 19%

Geron up 19%

Geron closed up 19% to $2.08 a share on 3.7 million shares. If it's up again Friday on at least 3 million shares then good news is coming. What could the news be. 1. A buyer and or partner for the stem cell business. 2. Three Phase 1 trials ended Jan 24th, they may have great results. 2.Geron's first stem cell patient has a news conference planned for Monday Jan. 30th. People think there is some big news will be released. Check Tory Minus blog for more details. I think it's possible all three may have good news. But the one that will move the share up the most is Number 1. If we go on light volume will sell just a few covered calls. If the price is up with good volume will wait.

ACTC down 3 days in a row. ACTC Chief Science Officer Robert Lanza sold 7.7 million shares for $1.5 million, still has 26 million shares after that sale. Still long, may buy more for a trade at around 12 cent.

Good luck in this rigged casino,

No comments:

Post a Comment